Evidence map›Paper›PMID 19185603›Full record

ArticleBrain research bulletin2009

MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling.

Emmanuel George Vrotsos, Pappachan E Kolattukudy, Kiminobu Sugaya

Open access · greenAbstract read
In one paragraph

Article in Brain research bulletin, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma.Journal of experimental & clinical cancer research : CR · 2021
    Article
  3. Article
  4. Article
  5. MCPIP1 RNase and Its Multifaceted Role.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Emmanuel George VrotsosBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816-2364, USA.
Pappachan E Kolattukudy
Kiminobu Sugaya
University of Central Florida · US

Funding

Neuroreplacement strategies by mesenchymal stem cellR01AG023472 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUGAYA, KIMINOBU · 2003 to 2007
$1.3M
NIA NIH HHS AG 23472NIA NIH HHS R01 AG023472
6 · The paper itself

Abstract

Previously it has been reported that neural stem cells undergoing apoptotic stress have increased levels of amyloid precursor protein (APP) and increased APP expression results in glial differentiation. APP activity was also shown to be required for staurosporine-induced glial differentiation of neuroprogenitor cells. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that is expressed early during inflammation. The binding of MCP-1 to its chemokine receptor induces expression of novel transcription factor MCP-1-induced protein (MCPIP). MCPIP expression subsequently leads to cell death. Previous studies have shown that pro-apoptotic factors have the ability to induce neural differentiation. Therefore, we investigated if MCPIP expression leads to differentiation of NT2 neuroprogenitor cells. Results showed that MCPIP expression increased glial fibrillary acid protein (GFAP) expression and also caused distinct morphological changes, both indicative of glial differentiation. Similar results were observed with MCP-1 treatment. Interestingly, APP expression decreased in response to MCPIP. Instead, we found APP activity regulates expression of both MCP-1 and MCPIP. Furthermore, inhibition of either p38 MAPK or JAK signaling pathways significantly reduced APP's effect on MCP-1 and MCPIP. These data demonstrates the role APP has in glial differentiation of NT2 cells through MCP-1/MCPIP signaling. It is possible that increased APP expression after CNS injury could play a role in MCP-1 production, possibly promoting astrocyte activation at injured site.

Indexed as

Cell DifferentiationAmyloid beta-Protein PrecursorCell DeathCell LineChemokine CCL2Glial Fibrillary Acidic ProteinHumansJanus KinasesMAP Kinase Signaling SystemNeurogliap38 Mitogen-Activated Protein KinasesPhosphorylationProtease NexinsReceptors, Cell SurfaceRibonucleasesRNA, MessengerAmyloid beta-Protein PrecursorAPP protein, humanCCL2 protein, humanChemokine CCL2Glial Fibrillary Acidic ProteinJanus Kinasesp38 Mitogen-Activated Protein KinasesProtease NexinsReceptors, Cell SurfaceRibonucleasesRNA, MessengerSTAT3 protein, humanSTAT3 Transcription FactorTranscription FactorsZC3H12A protein, human

Identifiers

PMID19185603
PMCPMC3427747
OpenAlexW2036429261

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.